MedTrace Logo

Progenitor Cell Therapy in Dilative Cardiomyopathy

NCT00284713 · Status: COMPLETED · Phase: PHASE1/PHASE2 · Type: INTERVENTIONAL · Enrollment: 30

Last updated 2009-02-18

No results posted yet for this study

Summary

Intracoronary infusion of bone marrow derived progenitor cells into the LAD in patients with non ischemic dilated cardiomyopathy.

Conditions

  • Heart Failure, Congestive
  • Cardiomyopathy, Dilated
  • Stem Cell Transplantation

Interventions

PROCEDURE

intracoronary infusion of BMC

catheter delivery of stem cells

Sponsors & Collaborators

  • Johann Wolfgang Goethe University Hospital

    lead OTHER

Principal Investigators

  • Andreas M Zeiher · Div. of Cardiology, University of Frankfurt, Germany

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2004-05-31
Primary Completion
2009-01-31
Completion
2009-01-31

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00284713 on ClinicalTrials.gov